Type de la demande
BR Brevet
Sous-type de la demande
BR Brevet PCT
(10) Numéro et date d'enregistrement
016216 2014.01.31
Satut
175
(180) Date d'expiration
2024.05.14
(20) Numéro et date de dépot
OA 1/2005/000352 2004.05.14
(40) Numéro et date de publication
(86) PCT Numéro et date de dépoôt
(87) PCT Numéro et date de publication
(85) Date d'entrée en phase Nationale
(30) Détails de la priorité
CN 03142399.X
2003.06.06
(71/73) Déposant
(FR) TIANJIN NORTH PHARMA SCI-TECH CO., LTD. : C35, Third Floor, No. 7, Kaihua Road, Huayuan, Sci-Tech Industry Garden
(FR) Tianjin Tasly Group Co., Ltd. : No. 1, Liaohe Dong Road, Beichen Hi-Tech Park, Beichen District
(72) Inventeur
(FR) WANG, Yongfeng : C35, Third Floor, No. 7, Kaihua Road, Huayuan, Sci-Tech Industry Garden
(FR) ZHAO, Kejun : No. 32, Zhujiang Road, Yantai Economic Development Area
(74) Nom du représentant
(FR) SCP NICO HALLE & Co. LAW FIRM : ADRESSE A COMPLETER
(54) intituler
(FR) 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole [2,3-d] pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof.
(57) Abrégé
(FR) The invention relates to the compounds of formula 1, their preparation and the pharmaceutical compositions containing the compounds. The invention also relates to the use of the compounds of formula I in preparing medicines, which can treat sexual dysfunction of animals including human (male and female), especially erectile dysfunction of male and the diseases in which the function of phospholipase 5 (cGMP PDE5) is involved. Formule 1
(58) Citations